Adaptive Biotechnologies Corp (ADPT)
Cost of Revenue
$75.68M
TTM · Period ending: · USD
ADPT Cost of Revenue
Latest reported$75.68Mperiod ending
Latest reported$75.68Mperiod ending
ADPT TTM Cost of Revenue ($19.67M → $75.68M)
TTM cost of revenue
High-resolution chart · PNG
ADPT cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 75,677,000 | |
| 73,088,000 | |
| 71,359,000 | |
| 71,180,000 | |
| 69,690,000 | |
| 71,008,000 | |
| 72,080,000 | |
| 73,651,000 | |
| 76,330,000 | |
| 74,923,000 | |
| 75,553,000 | |
| 72,526,000 | |
| 68,087,000 | |
| 63,398,000 | |
| 57,909,000 | |
| 55,676,000 | |
| 54,958,000 | |
| 52,502,000 | |
| 49,301,000 | |
| 41,167,000 | |
| 33,031,000 | |
| 27,178,000 | |
| 22,530,000 | |
| 22,259,000 | |
| 21,807,000 | |
| 22,629,000 | |
| 22,274,000 | |
| 21,598,000 | |
| 21,357,000 | |
| 20,667,000 | |
| 19,668,000 |